GALLIVAC SE

Oral Lyophilisate

IDT Biologika GmbHVPA10524/007/001

Main Information

Trade NameGALLIVAC SE
Active SubstancesSALMONELLA ENTERITIDIS MUTANT, STRAIN NO 441/014, GENETICALLY STABLE, DOUBLE-ATTENUATED
Strength
Dosage FormOral Lyophilisate
Licence HolderIDT Biologika GmbH
Licence NumberVPA10524/007/001

Group Information

ATC CodeQI01AE01 salmonella
Therapeutic ClassImmunological - Live Vaccine
SpeciesChickens

Status

Authorised/WithdrawnAuthorised
Licence Issued02/12/2016
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back